Price Prediction: Synopsys Will Trade at 2027 Target
Synopsys posted solid quarterly results but faces Design IP headwinds. The path to a 2027 price target hinges on marg...
This volatility comparison pits the dividend aristocrats ETF against the SP500 to help you evaluate relative risk and inform allocation decisions.
20,523 articlesSynopsys posted solid quarterly results but faces Design IP headwinds. The path to a 2027 price target hinges on marg...
When an institutional investor takes a large position in a biotech stock, it can signal potential credibility or risk...
As AI enthusiasm cools, investors pivot to hard assets. New data show demand data center power rising faster than exp...
When a growth stock slides after earnings, it can shake your confidence. This guide explains why oddity tech stock pl...
Fame often comes with hidden costs. In this piece, we unpack Cara Delevingne's reflections on her Victoria’s Secret y...
Bank of America climbs as a cross-border real-time payments plan expands. This development could steer the stock mark...
In the AI boom, everyone chase chips and models. But the most important company you've probably never heard of sits b...
American Airlines is pausing six domestic routes this summer amid spike in jet fuel costs tied to Middle East tension...
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Casey’s General Stores prepares to report Q4 results after the bell, with analysts weighing margins in prepared foods...
Intel reveals a slate of high-impact partnerships and capacity expansions that could redefine its role in AI and clou...
A coalition of silicon valley insiders warns that the United States is underprepared for modern warfare, with wide-re...